Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Clinical Psychology›Generalized Anxiety Disorder-7
Process / pipelinegeneralized anxiety screening

Generalized Anxiety Disorder-7

Generalized Anxiety Disorder-7 Scale · Also known as: GAD-7

The GAD-7 is a brief 7-item self-report questionnaire designed to screen for and measure the severity of generalized anxiety disorder in adolescents and adults. Developed by Spitzer, Kroenke, Williams, and Löwe in 2006, it has become one of the most widely used anxiety screening tools in primary care, mental health research, and clinical practice due to its brevity, excellent psychometric properties, and ease of administration.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Generalized Anxiety Disorder-7
Beck Anxiety InventoryPenn State Worry Questio…State-Trait Anxiety Inve…Brief Phobia ScalesCorah Dental Anxiety Sca…Health Anxiety InventoryLiebowitz Social Anxiety…Panic Disorder Severity…Social Interaction Anxie…

When to use it

The GAD-7 is recommended for screening and symptom severity monitoring in primary care, emergency departments, mental health clinics, and research settings. It is suitable for adolescents (aged 12 and older) and adults. Use it as an initial screening tool before formal diagnostic assessment, as a baseline measure before treatment, or as a repeated measure to track response to intervention. It is less suitable for diagnosing specific anxiety disorders (e.g., social anxiety disorder, panic disorder) alone, and should not be used in isolation for diagnostic decision-making.

Strengths & limitations

Strengths
  • Brevity and efficiency — 7 items completed in under 3 minutes, facilitating use in busy clinical settings.
  • Excellent psychometric properties — internal consistency (Cronbach's α ≥ 0.88), good convergent validity with longer anxiety measures, and strong test-retest reliability.
  • Sensitivity and specificity — at the cutoff score of 10, demonstrates 89% sensitivity and 97% specificity for GAD in primary care populations.
  • Validated across populations — extensively translated and validated in 50+ languages, clinically useful in diverse cultural and health-care settings.
Limitations
  • Screening tool, not diagnostic — GAD-7 cannot confirm a diagnosis of generalized anxiety disorder; clinical interview is required.
  • High sensitivity to change may complicate measurement stability — even small fluctuations in worry can shift scores, potentially reducing specificity for severe cases.
  • Does not assess worry content — by design, it measures frequency and intensity but not the themes or domains of worry, limiting clinical formulation.

Frequently asked

Can the GAD-7 be used to diagnose generalized anxiety disorder?

No. The GAD-7 is a screening and severity measure, not a diagnostic tool. Diagnosis requires a clinical interview assessing DSM-5 criteria (worry present more days than not for at least 6 months, difficulty controlling worry, associated physical or cognitive symptoms). Use GAD-7 as the first step; elevated scores should prompt further diagnostic evaluation.

What is the best cutoff score to use?

In primary care, a cutoff of 10 is commonly used (maximizing sensitivity and specificity for GAD). However, some clinicians use 8 for higher sensitivity when screening is prioritized. For monitoring treatment response, even small changes (e.g., 2–3 points) may be clinically meaningful. Consider your setting and population when selecting a cutoff.

Is the GAD-7 free to use?

Yes. The GAD-7 is in the public domain and free for clinical and research use without permission or license fee. It is available in numerous languages and can be downloaded from peer-reviewed publications or the authors' websites.

How often should I administer the GAD-7 during treatment?

There is no fixed schedule. In clinical practice, administering it at baseline, every 4 weeks during active treatment, and at termination is common. Some therapies (e.g., cognitive-behavioral therapy) may use weekly administration. For research, use your protocol's specified intervals.

Sources

  1. Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097. DOI: 10.1001/archinte.166.10.1092 ↗

How to cite this page

ScholarGate. (2026, June 3). Generalized Anxiety Disorder-7 Scale. ScholarGate. https://scholargate.app/en/clinical-psychology/gad-7

Related methods

Beck Anxiety InventoryPenn State Worry QuestionnaireState-Trait Anxiety Inventory

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Beck Anxiety InventoryClinical Psychology↔ compare
  • Penn State Worry QuestionnaireClinical Psychology↔ compare
  • State-Trait Anxiety InventoryClinical Psychology↔ compare
Compare side by side →

Referenced by

Beck Anxiety InventoryBrief Phobia ScalesCorah Dental Anxiety ScaleHealth Anxiety InventoryLiebowitz Social Anxiety ScalePanic Disorder Severity ScalePenn State Worry QuestionnaireSocial Interaction Anxiety ScaleState-Trait Anxiety Inventory

Similar methods

Generalized Anxiety Disorder ScalePenn State Worry QuestionnaireGAIBeck Anxiety InventoryCOVID-19 Anxiety ScaleHealth Anxiety InventoryHamilton Anxiety Rating ScaleGeneral Health Questionnaire

Related reference concepts

Depression and Anxiety ScreeningDepression and Anxiety Disorder ScreeningGeneralized Anxiety DisorderGeneralized Anxiety DisorderAnxiety DisordersAnxiety Disorders

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Generalized Anxiety Disorder-7 (Generalized Anxiety Disorder-7 Scale). Retrieved 2026-07-21 from https://scholargate.app/en/clinical-psychology/gad-7 · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Robert L. Spitzer, Kurt Kroenke, Janet B. Williams, Bernd Löwe
Subfamily
generalized anxiety screening
Year
2006
Type
Self-report screening questionnaire
Related methods
Beck Anxiety InventoryPenn State Worry QuestionnaireState-Trait Anxiety Inventory
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account